Philippe Sollie, Bpharm
CEO
Flen Health
1980 B. Phil (University of Antwerp)
1983 M. Pharm (University of Antwerp)
1984 M. Ind Pharm. (University of Antwerp)
1986 Pharmaceutical engineer (University of Louvain)
2000 Founder Flen Pharma
What is now the mission of Flen Health: a world where wounds and skin disorders do not prevent patients from living the life, they love, started at a friends barbecue. A little girl (1year old) accidentally burned herself with fryer oil. She suffered severe burns and due to the young girl's allergies the existing treatments cannot be used on her. Philippe Sollie looked for ways to help the little girl and in collaboration with clinicians he invented Flamigel and thereafter Flaminal a new formula to treat chronic and acute wounds. Seeing the happiness of the parents and the little girl due to the success of the product Philippe Sollie founded Flen Health so he could keep on helping people with inflammatory diseases live the live they love.
Flen Health has research and commercialised patented wound care products across the globe: 7 affiliates (Benelux, UK, Germany, Ireland, Dubai) and distribution agreements in 40+ countries and 100+ Flenners are helping patients living the life they love.